These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 4585358

  • 21. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS, Jogaikar DG, Mehta JM.
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [Abstract] [Full Text] [Related]

  • 22. [Levamisole -- a drug modifying immunologic phenomena].
    Bogdanikowa B.
    Postepy Hig Med Dosw; 1979 Jan; 33(2):125-46. PubMed ID: 384382
    [No Abstract] [Full Text] [Related]

  • 23. Effect of levamisole on skin reactions to DNCB in chronically dialyzed patients.
    Modai D, Sagi DB, Maor J.
    Nephron; 1980 Jan; 25(6):280-2. PubMed ID: 7393370
    [Abstract] [Full Text] [Related]

  • 24. Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy.
    Ellegaard J, Boesen AM.
    Scand J Haematol; 1976 Jul; 17(1):36-43. PubMed ID: 134452
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G, Renoux M.
    Nouv Presse Med; 1976 Jan 10; 5(2):67-70. PubMed ID: 772602
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II, Skakal'skaia LM.
    Vrach Delo; 1982 Aug 10; (8):4-8. PubMed ID: 6983185
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Effect of levamisole on various indicators of cellular immunity in amyloidosis].
    Khasabov NN, Mukhin NA, Sura VV, Osipova IN, Varshavskiĭ VA.
    Ter Arkh; 1978 Aug 10; 50(2):115-9. PubMed ID: 644475
    [No Abstract] [Full Text] [Related]

  • 31. [Levamisole - a new immunostimulant].
    Rachkov SM.
    Ter Arkh; 1976 Aug 10; 48(11):133-8. PubMed ID: 1088219
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Modulation of host response during infection with Trichinella pseudospiralis using immuno-stimulant drug.
    Boulos LM, Hegazy IH, Abou-Seif M, Abdel-Kader M.
    J Egypt Soc Parasitol; 1993 Apr 10; 23(1):1-8. PubMed ID: 8482856
    [Abstract] [Full Text] [Related]

  • 34. Potentiation of T-cell mediated immunity by levamisole.
    Renoux G, Renoux M, Teller MN, McMahon S, Guillaumin JM.
    Clin Exp Immunol; 1976 Aug 10; 25(2):288-96. PubMed ID: 782749
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Levamisole effects on collagen disease lymphocytes in vitro and in vivo (author's transl)].
    Hoshina H.
    Nihon Naika Gakkai Zasshi; 1979 Jun 10; 68(6):620-30. PubMed ID: 479657
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human monocyte-lymphocyte interaction and its enhancement by levamisole.
    Kazura JW, Negendank W, Guerry D, Schreiber AD.
    Clin Exp Immunol; 1979 Feb 10; 35(2):258-68. PubMed ID: 312172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.